Recent Quotes (30 days)

You have no recent quotes
chg | %

Atrium Innovations Inc.  

(Public, TSE:ATB)   Watch this stock  
Find more results for atb
14.14
+0.03 (0.21%)
May 23 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 14.00 - 14.25
52 week 9.90 - 14.49
Open 14.05
Vol / Avg. 20,787.00/38,625.00
Mkt cap 442.95M
P/E 11.52
Div/yield     -
EPS 1.23
Shares 31.33M
Beta 0.43
Inst. own     -
Aug 5, 2013
Q2 2013 ATRIUM INNOVATIONS INC Earnings Release Add to calendar
May 14, 2013
ATRIUM INNOVATIONS INC Annual Shareholder Meeting
May 14, 2013
Q1 2013 ATRIUM INNOVATIONS INC Earnings Conference Call
May 13, 2013
Q1 2013 ATRIUM INNOVATIONS INC Earnings Release
Feb 28, 2013
Q4 2012 ATRIUM INNOVATIONS INC Earnings Conference Call
Feb 25, 2013
Q4 2012 ATRIUM INNOVATIONS INC Earnings Release
  

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 11.62% 8.05%
Operating margin 17.33% 11.36%
EBITD margin - 19.36%
Return on average assets 6.75% 4.26%
Return on average equity 12.55% 8.20%
Employees 1,100 -
Carbon Disclosure Rating - -

Address

1405 boulevard du Parc-Technologique
QUEBEC, QC G1P 4P5
Canada
+1-418-6521116 (Phone)
+1-418-6520151 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

Atrium Innovations Inc. (Atrium) is a Canada-based company engaged in the development, manufacturing, and commercialization of dietary supplements endorsed by health professionals. The Company owns more than 16 brands of products which are distributed mainly in the healthcare practitioner and health food and specialized store channels in more than 35 countries, with a primary focus in North America and Europe. The Company manufactures and markets more than 2,000 health and nutrition finished products. The products are generated primarily from natural sources and include vitamins, minerals and specialized products such as enzymes, probiotics and omega-3. They are marketed primarily through healthcare practitioners mostly in North America and Europe, such as physicians, chiropractors and naturopaths, as well as through health food stores and direct to consumer, and are generally based on scientifically supported formulas to deliver the expected health benefits.

Officers and directors

Pierre Laurin Ph.D. Independent Chairman of the Board
Age: 73
Pierre Fitzgibbon President, Chief Executive Officer, Director
Age: 58
Alain Bouchard Independent Vice Chairman of the Board
Mario Paradis Chief Financial Officer, Vice President
Carmen Fortino President, North American Operations
Age: 52
Paul Hannema Executive Vice President - Head of European Operations
Serge Yelle Ph.D. Executive Vice President - Strategy and Business Development
Annie Blanchette Vice President - Human Resources
David Torralbo Vice President - Corporate and Legal Affairs, Secretary
Barry Ritz Vice President - Scientific and Regulatory Affairs